SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-028204
Filing Date
2021-05-17
Accepted
2021-05-17 08:56:58
Documents
56
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q arpo-10q_20210331.htm 10-Q 1495998
2 EX-31.1 arpo-ex311_7.htm EX-31.1 21752
3 EX-31.2 arpo-ex312_9.htm EX-31.2 22989
4 EX-32.1 arpo-ex321_6.htm EX-32.1 10531
5 EX-32.2 arpo-ex322_8.htm EX-32.2 11770
  Complete submission text file 0001564590-21-028204.txt   4609735

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT arpo-20210331.xml EX-101.INS 796476
7 XBRL TAXONOMY EXTENSION SCHEMA arpo-20210331.xsd EX-101.SCH 36202
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arpo-20210331_cal.xml EX-101.CAL 24917
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arpo-20210331_def.xml EX-101.DEF 86837
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE arpo-20210331_lab.xml EX-101.LAB 294578
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arpo-20210331_pre.xml EX-101.PRE 214179
Mailing Address 9987 CARVER ROAD CINCINNATI OH 45242
Business Address 9987 CARVER ROAD CINCINNATI OH 45242 (513) 985-1920
Aerpio Pharmaceuticals, Inc. (Filer) CIK: 0001422142 (see all company filings)

IRS No.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38560 | Film No.: 21927887
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences